162 related articles for article (PubMed ID: 20412067)
1. Neutral endopeptidase inhibition: could it have a role in the treatment of female sexual arousal disorder?
Angulo J
Br J Pharmacol; 2010 May; 160(1):48-50. PubMed ID: 20412067
[TBL] [Abstract][Full Text] [Related]
2. UK-414,495, a selective inhibitor of neutral endopeptidase, potentiates pelvic nerve-stimulated increases in female genital blood flow in the anaesthetized rabbit.
Wayman CP; Baxter D; Turner L; Van Der Graaf PH; Naylor AM
Br J Pharmacol; 2010 May; 160(1):51-9. PubMed ID: 20412068
[TBL] [Abstract][Full Text] [Related]
3. Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder. Synthesis and activity of functionalized glutaramides.
Pryde DC; Maw GN; Planken S; Platts MY; Sanderson V; Corless M; Stobie A; Barber CG; Russell R; Foster L; Barker L; Wayman C; Van Der Graaf P; Stacey P; Morren D; Kohl C; Beaumont K; Coggon S; Tute M
J Med Chem; 2006 Jul; 49(14):4409-24. PubMed ID: 16821800
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil augments pelvic nerve-mediated female genital sexual arousal in the anesthetized rabbit.
Min K; Kim NN; McAuley I; Stankowicz M; Goldstein I; Traish AM
Int J Impot Res; 2000 Sep; 12 Suppl 3():S32-9. PubMed ID: 11002397
[TBL] [Abstract][Full Text] [Related]
5. Influence of sildenafil on genital engorgement in women with female sexual arousal disorder.
Leddy LS; Yang CC; Stuckey BG; Sudworth M; Haughie S; Sultana S; Maravilla KR
J Sex Med; 2012 Oct; 9(10):2693-7. PubMed ID: 22620487
[TBL] [Abstract][Full Text] [Related]
6. Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder.
Pryde DC; Cook AS; Burring DJ; Jones LH; Foll S; Platts MY; Sanderson V; Corless M; Stobie A; Middleton DS; Foster L; Barker L; Van Der Graaf P; Stacey P; Kohl C; Coggon S; Beaumont K
Bioorg Med Chem; 2007 Jan; 15(1):142-59. PubMed ID: 17070062
[TBL] [Abstract][Full Text] [Related]
7. Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder.
Berman JR; Berman LA; Lin H; Flaherty E; Lahey N; Goldstein I; Cantey-Kiser J
J Sex Marital Ther; 2001; 27(5):411-20. PubMed ID: 11554201
[TBL] [Abstract][Full Text] [Related]
8. Vardenafil enhances clitoral and vaginal blood flow responses to pelvic nerve stimulation in female dogs.
Angulo J; Cuevas P; Cuevas B; Bischoff E; Sáenz de Tejada I
Int J Impot Res; 2003 Apr; 15(2):137-41. PubMed ID: 12789394
[TBL] [Abstract][Full Text] [Related]
9. Psychophysiological assessment in premenopausal sexual arousal disorder.
Brotto LA; Basson R; Gorzalka BB
J Sex Med; 2004 Nov; 1(3):266-77. PubMed ID: 16422956
[TBL] [Abstract][Full Text] [Related]
10. A review of the physiology and pharmacology of peripheral (vaginal and clitoral) female genital arousal in the animal model.
Munarriz R; Kim SW; Kim NN; Traish A; Goldstein I
J Urol; 2003 Aug; 170(2 Pt 2):S40-4; discussion S44-5. PubMed ID: 12853772
[TBL] [Abstract][Full Text] [Related]
11. The discovery of small molecule inhibitors of neutral endopeptidase. Structure-activity studies on functionalized glutaramides.
Maw GN; Stobie A; Planken S; Pryde DC; Sanderson V; Platts MY; Corless M; Stacey P; Wayman C; Van Der Graaf P; Kohl C; Coggon S; Beaumont K
Chem Biol Drug Des; 2006 Jan; 67(1):74-7. PubMed ID: 16492151
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of alprostadil cream for the treatment of female sexual arousal disorder: a double-blind, placebo-controlled study in chinese population.
Liao Q; Zhang M; Geng L; Wang X; Song X; Xia P; Lu T; Lu M; Liu V
J Sex Med; 2008 Aug; 5(8):1923-31. PubMed ID: 18564348
[TBL] [Abstract][Full Text] [Related]
13. FSFI scores of women with persistent genital arousal disorder compared with published scores of women with female sexual arousal disorder and healthy controls.
Leiblum SR; Seehuus M
J Sex Med; 2009 Feb; 6(2):469-73. PubMed ID: 19040625
[TBL] [Abstract][Full Text] [Related]
14. A phase 2a multicenter, double-blind, placebo-controlled, crossover trial to investigate the efficacy, safety, and toleration of CP-866,087 (a high-affinity mu-opioid receptor antagonist) in premenopausal women diagnosed with female sexual arousal disorder (FSAD).
Orri M; Abraham L; Giraldi A
J Sex Med; 2013 Oct; 10(10):2484-96. PubMed ID: 23347610
[TBL] [Abstract][Full Text] [Related]
15. [Female sexual dysfunction: a systematic overview of classification, pathophysiology, diagnosis and treatment].
Marthol H; Hilz MJ
Fortschr Neurol Psychiatr; 2004 Mar; 72(3):121-35. PubMed ID: 14999592
[TBL] [Abstract][Full Text] [Related]
16. I. Slow oscillations in vaginal blood flow: alterations during sexual arousal in rodents and humans.
Allers KA; Richards N; Sultana S; Sudworth M; Dawkins T; Hawcock AB; Buchanon T; Casey JH; Wayman C
J Sex Med; 2010 Mar; 7(3):1074-87. PubMed ID: 19732310
[TBL] [Abstract][Full Text] [Related]
17. The physiology and causes of female sexual arousal disorder: part I.
Feldhaus-Dahir M
Urol Nurs; 2009; 29(6):440-3. PubMed ID: 20088237
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant-induced inhibition of genital vascular responses is reversed by vardenafil in female rabbits.
Angulo J; Cuevas P; Cuevas B; Bischoff E; De Tejada IS
J Sex Med; 2006 Nov; 3(6):988-995. PubMed ID: 17100931
[TBL] [Abstract][Full Text] [Related]
19. Neurophysiology and pharmacology of female genital sexual response.
Giuliano F; Rampin O; Allard J
J Sex Marital Ther; 2002; 28 Suppl 1():101-21. PubMed ID: 11898692
[TBL] [Abstract][Full Text] [Related]
20. Effects of ovariectomy and estrogen and androgen treatment on sildenafil-mediated changes in female genital blood flow and vaginal lubrication in the animal model.
Min K; Munarriz R; Kim NN; Goldstein I; Traish A
Am J Obstet Gynecol; 2002 Nov; 187(5):1370-6. PubMed ID: 12439533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
